SAN DIEGO--(BUSINESS WIRE)-- #5hmC--ClearNote Health's Avantect Pancreatic Cancer Test will now be available to members accessing Claritev's national PHCS and MultiPlan Networks.
MultiPlan Corporation (MPLN) came out with a quarterly loss of $5.14 per share versus the Zacks Consensus Estimate of a loss of $2.33. This compares to loss of $2.40 per share a year ago.
NEW YORK--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today a corporate rebrand to Claritev. The Company will also start trading with a new ticker, CTEV, on the New York Stock Exchange on February 28, 2025. Founded in 1980, the Company plays a significant role in delivering access to care through provider.
MultiPlan (MPLN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
NEW YORK--(BUSINESS WIRE)---- $MPLN #MPLN--MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading provider of technology and data solutions that improve affordability, quality and transparency in healthcare, today announced an agreement with J2 Health, a cloud-based software solution that optimizes provider network performance. This strategic agreement will support MultiPlan's network optimization strategy, providing tailored solutions and resource efficiency that ultimately reduces healt.
NEW YORK--(BUSINESS WIRE)---- $MPLN #MPLN--MultiPlan Corporation (NYSE: MPLN) (“MultiPlan” or the “Company”), a leading provider of technology and data solutions focused on cost management, improving quality and transparency in healthcare, today announced a comprehensive refinancing to extend the maturities of its entire debt capital structure. MultiPlan has entered into an agreement (the “Transaction Support Agreement”) with certain ad hoc groups of noteholders and lenders collectively beneficially owning app.
MultiPlan Corporation (NYSE:MPLN ) Q3 2024 Earnings Conference Call November 5, 2024 8:30 AM ET Company Participants Shawna Gasik - AVP, IR Travis Dalton - CEO Doug Garis - CFO Conference Call Participants Joshua Raskin - Nephron Research Daniel Grosslight - Citigroup Jessica Tassan - Piper Sandler Madison Aron - JPMorgan Operator Hello and welcome to the MultiPlan Corporation Third Quarter 2024 Earnings Call. My name is Harry and I will be your operator today.
MultiPlan Corporation (MPLN) came out with a quarterly loss of $1.85 per share versus the Zacks Consensus Estimate of a loss of $2.37. This compares to loss of $2.40 per share a year ago.
NEW YORK--(BUSINESS WIRE)--MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton said, “During the third quarter, we experienced growth in volumes of billed charges and identified.
NEW YORK--(BUSINESS WIRE)---- $MPLN #MPLN--MultiPlan Corporation (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, is accepting applications for its Rural Health Grant now through December 15, 2024 from rural healthcare providers in the U.S. The grants provide financial resources to introduce or expand services, education, screenings and other programs aimed at improving the health.